In Almond, Doyle, Kowalski and Williams (2010), we describe how marginal returns to medical care can be estimated by comparing patients on either side of diagnostic thresholds. Our application examines at-risk newborns near the very low birth weight threshold at 1500 grams. We estimate large discontinuities in medical care and mortality at this threshold, with effects concentrated at "lowquality" hospitals. While our preferred estimates retain newborns near the threshold, when they are excluded the estimated marginal returns decline, although they remain large. In low-quality hospitals, our estimates are similar in magnitude regardless of whether these newborns are included or excluded.
more medical care and have lower mortality compared to those weighing slightly more. The empirical estimates suggest large returns to medical care for these at-risk newborns.
Figure I of ADKW is a histogram of reported births near 1500g, showing pronounced mass points at whole ounces and smaller mass points at 100g intervals. Motivated by this histogram, Barreca, Guldi, Lindo, and Waddell (BGLW) examine a series of alternative specifications. Initially, they exclude newborns with reported birth weights at exactly 1500g. The estimated mortality discontinuity on this sample is smaller in magnitude, although it continues to be both statistically and economically significant. Subsequently, they exclude successively larger sets of newborns, up to a maximum of 1497g to 1503g (inclusive)-a sample restriction that removes 25% of the control observations and 0.38% of the treatment observations, with the asymmetry due to a mass point at 1503g (3lbs 5oz). The estimated mortality discontinuity on this sample declines somewhat and is no longer statistically significant.
Although there is no general economic or statistical case for exclusion of observations at or around the threshold in a regression discontinuity (RD) design, given the specific details of our application we agree that the exclusion of newborns at 1500g is a useful robustness check that we should have included in our original paper. In contrast, we see no clear case for excluding the larger set of newborns from 1497g to 1503g, and we find that doing so changes the sample composition such that we would in fact expect smaller discontinuity estimates. Regardless, the two welfare-relevant results from ADKW are robust to the inclusion or exclusion of newborns at and around 1500g: we continue to find that discontinuities in both medical care and mortality are concentrated in low-quality hospitals, and our two-sample, two-stage least squares estimate continues to suggest large returns to medical care for these newborns. Below, we discuss these issues in more detail.
First, consider BGLW's exclusion of newborns reported to weigh exactly 1500g. The main empirical concern is that less healthy newborns may be disproportionately likely to have their birth weight rounded to 1500g.
1 Supporting this hypothesis is the fact that newborns at exactly 1500g are anomalous based on ex ante fixed characteristics such as race and mother's education. Less supportive of this hypothesis is that although we would expect less healthy newborns to receive correspondingly higher levels of medical care, this is not observed empirically: mean hospital charges for newborns at 1500g are $83,000, which is in line with mean hospital charges in the one-ounce bin above the threshold ($85,000), and is $11,000 less than mean hospital charges in the one-ounce bin below the threshold.
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Given this concern, we agree that the exclusion of newborns at 1500g from the analysis is a useful robustness check. When these newborns are excluded, the mortality discontinuity is smaller in magnitude, although we continue to estimate statistically and economically significant discontinuities in both mortality and medical care. 3 The estimates including or excluding newborns at 1500g are not statistically distinguishable. 4 Our preferred estimate includes newborns at 1500g, especially because the medical care received by these newborns is in line with that of other non-VLBW newborns above 1500g-suggesting that these observations have not been misclassified.
Second, we find that the hospital heterogeneity results presented in our original paper are robust to BGLW's proposed sample restrictions. In Section VII of ADKW, we use quality measures of Neonatal Intensive Care Units (NICUs) available for California to investigate heterogeneity in treatment effects across hospitals. At hospitals with high-level NICUs (3a/3b/3c/3d), the 1500g threshold does not appear to determine medical care, and no mortality discontinuity is observed. At hospitals with low-level NICUs (0/1/2 or no NICU), we find substantial discontinuities in both medical care and mortality. Although in theory these results could have been driven by differential propensities to report newborns at 1500g across hospitals, Table 1 shows this is not the case. For example, at hospitals with low-level NICUs, the mortality discontinuity is 3.7 percentage points; when observations at 1500g and 1497-1503g are excluded, the estimates are 3.3 percentage points and 4.0 percentage points, respectively. The medical care discontinuity is relatively stable, although is smaller in magnitude and less precise as additional newborns are excluded.
Third, we find that the main welfare-relevant estimates in ADKW-the estimated returns to medical care-are also robust to BGLW's proposed sample restrictions. BGLW confine their analysis to reduced form mortality effects. We extend their analysis by combining discontinuities in medical care and mortality to estimate the returns to medical care. Our original point estimates imply that the cost of saving a statistical life is $527,000 (using the full sample of mortality data) or $615,000 (using mortality data from the five states for which we observe hospital discharge data). Dropping the observations at 1500g changes these estimates, respectively, to $1.32 million and $1.05 million.
Dropping the observations from 1497g to 1503g changes these estimates, respectively, to $1.53 million and $584,000. 5 While the estimates excluding newborns at and around 1500g are less cost-effective than our original estimates, these estimates all fall near or within the asymptotic 95% confidence interval of our original five-state estimate, which was $30,000 to $1.2 million. In addition, all of the estimates are well below conventional value of life estimates for this population, which are on the order of $3 million.
Finally, consider BGLW's exclusion of the larger set of newborns from 1497g to 1503g. The pivotal aspect of this sample restriction is that newborns on the mass point at 1503g (3lbs 5oz) are
excluded. There appears to be no clear a priori case for excluding these newborns. Much of our data is found at ounce intervals, and there is no visible or statistical evidence of discontinuities in ex ante fixed characteristics across the threshold ( Figure V and Appendix Table A2 of ADKW).
In extending BGLW's analysis, we find that the exclusion of newborns on this mass point at 1503g induces a sample-selection bias by changing the hospital composition such that the smaller observed mortality and medical care discontinuities on this restricted sample are not surprising. The propensity to report at ounce mass points differs across hospitals: hospitals with low-level NICUs are 60% more likely to report birth weight on whole ounces relative to hospitals with high-level NICUs.
This means that dropping the mass point at 1503g changes the sample composition of hospitals just above the threshold, differentially excluding newborns at hospitals with low-level NICUs. 6 That is, among newborns just above the threshold, higher-quality hospitals are overrepresented in this restricted sample. Because higher-quality hospitals have lower mortality rates and higher costs (Table   1) , in this restricted sample newborns just above the threshold have higher costs and lower mortality relative to newborns just above the threshold in the full sample. This induced over-representation of newborns with lower mortality just above the threshold implies we should expect a smaller discontinuous increase in mortality at the threshold in the restricted sample relative to the full sample.
Similarly, this induced over-representation means we should also expect a smaller discontinuous decrease in hospital costs at the threshold. In summary, the smaller discontinuities in mortality and hospitals costs in the sample excluding newborns from 1497g-1503g are both expected and consistent with our original hospital-heterogeneity findings.
To conclude, BGLW question whether the observed variation in medical care and mortality across the 1500g threshold is informative for estimating the marginal returns to medical care for these newborns. Our reading of the evidence suggests this variation is informative. In the end, regardless of whether the observations at and around 1500g are retained, the evidence continues to suggest large returns to medical care for these at-risk newborns, with effects concentrated in low-quality hospitals. 
